Converging evidence points towards a role of insulin signaling in regulating compulsive behavior

Ilse I G M van de Vondervoort, Houshang Amiri, Muriel M K Bruchhage, Charlotte A Oomen, Nitin Rustogi, Jason D Cooper, Jack J A van Asten, Arend Heerschap, Sabine Bahn, Steven C R Williams, Jan K Buitelaar, Geert Poelmans, Jeffrey C Glennon, Ilse I G M van de Vondervoort, Houshang Amiri, Muriel M K Bruchhage, Charlotte A Oomen, Nitin Rustogi, Jason D Cooper, Jack J A van Asten, Arend Heerschap, Sabine Bahn, Steven C R Williams, Jan K Buitelaar, Geert Poelmans, Jeffrey C Glennon

Abstract

Obsessive-compulsive disorder (OCD) is a neuropsychiatric disorder with childhood onset, and is characterized by intrusive thoughts and fears (obsessions) that lead to repetitive behaviors (compulsions). Previously, we identified insulin signaling being associated with OCD and here, we aim to further investigate this link in vivo. We studied TALLYHO/JngJ (TH) mice, a model of type 2 diabetes mellitus, to (1) assess compulsive and anxious behaviors, (2) determine neuro-metabolite levels by 1 H magnetic resonance spectroscopy (MRS) and brain structural connectivity by diffusion tensor imaging (DTI), and (3) investigate plasma and brain protein levels for molecules previously associated with OCD (insulin, Igf1, Kcnq1, and Bdnf) in these subjects. TH mice showed increased compulsivity-like behavior (reduced spontaneous alternation in the Y-maze) and more anxiety (less time spent in the open arms of the elevated plus maze). In parallel, their brains differed in the white matter microstructure measures fractional anisotropy (FA) and mean diffusivity (MD) in the midline corpus callosum (increased FA and decreased MD), in myelinated fibers of the dorsomedial striatum (decreased FA and MD), and superior cerebellar peduncles (decreased FA and MD). MRS revealed increased glucose levels in the dorsomedial striatum and increased glutathione levels in the anterior cingulate cortex in the TH mice relative to their controls. Igf1 expression was reduced in the cerebellum of TH mice but increased in the plasma. In conclusion, our data indicates a role of (abnormal) insulin signaling in compulsivity-like behavior.

Conflict of interest statement

I.v.deV., H.A., M.B., C.O., N.R., J.C., J.v.A., A.H., S.W. and G.P. report no financial conflict of interest. S.B. is a director of Psynova Neurotech Ltd and PsyOmics Ltd. In the past 2 years, J.K.B. was a consultant to/member of advisory board of/and/or speaker for Janssen-Cilag BV, Eli Lilly, Shire, Novartis, Roche, and Servier. J.C.G. has in the past three years been a consultant to Boehringer Ingelheim GmbH. Neither J.K.B. nor J.C.G. are employees of any of these companies, and neither are stock shareholders of any of these companies.

Figures

Fig. 1. Increased compulsive- and anxiety-like behaviours…
Fig. 1. Increased compulsive- and anxiety-like behaviours are observed in TALLYHO/JngJ mice while compulsive behaviour correlates with blood glucose levels.
a TALLYHO/JngJ (TH) mice show increased compulsive behavior compared to SWR/J mice (the control strain), as seen in a decrease in the spontaneous alternation behavior (37.4 ± 6.8 vs. 62.3 ± 2.1% spontaneous alternation, n = 9 per strain, p = 0.006). b In addition, an increase in the number of repeated arm entries was observed in the TH mice (11.3 ± 4.0 vs. 1.48 ± 0.74% of the total arm entries being repeated arm entries, n = 9 per strain, p = 0.041). c No difference was observed between the two strains in compulsive marble burying (8.2 ± 1.7 vs. 10.1 ± 1.1 marbles buried, n = 9 per strain, p = 0.365). d In addition, TH mice display increased anxiety behavior: a trend was observed toward a TH mice spending less time in the center zone of the open field compared with SWR/J mice (204.6 ± 26.6 vs. 254.2 ± 16.5 s, n = 4 per strain, p = 0.174). e More importantly, TH mice spent less time in the open arms of the elevated plus maze (EPM), suggesting increased anxiety (3.8 ± 0.98 versus 23.7 ± 2.97 s, n = 7 [TH] and n = 9 [SWR/J], p = 0.000096). f Blood glucose levels were negatively correlated with spontaneous alternation behavior (r = −0.495, n = 18, p = 0.037)
Fig. 2. MRS revealed differences in the…
Fig. 2. MRS revealed differences in the metabolite content of the dorsomedial striatum (DMS) and anterior cingulate cortex (ACC) in TALLYHO/JngJ mice.
The metabolites of interest are glutamate (Glu), glutamine (Gln), taurine (Tau), N-acetylaspartate (NAA), sum of myo-Inositol and glycine (mI + Gly), total choline (tCho), glucose (Glc), GABA, and glutathione (GSH). MRS data are expressed as ratios of the metabolites relative to the total creatine (tCr) levels. a Glucose (Glc) ratios (relative to tCr) were increased in brains of TALLYHO/JngJ (TH) mice in the DMS compared with the control strain (SWR/J mice) (0.527 ± 0.025 vs. 0.308 ± 0.035, n = 9 [TH] and n = 7 [SWR/J], p = 0.0031). b An increase in glutathione (GSH) ratios (relative to tCr) was observed in the ACC of TH mice (0.325 ± 0.021 and 0.212 ± 0.028, n = 9 [TH] and n = 6 [SWR/J], p = 0.047). Differences in the other metabolites (glutamate [Glu] glutamine [Gln], taurine [Tau], N-acetylaspartate [NAA], the sum of myo-Inositol and glycine [mI + Gly], total choline [tCho], and GABA) failed to reach significance. c Blood glucose concentrations correlated with DMS Glc concentration (r = 0.664, n = 16, p = 0.005). d No significant correlation was observed between the blood glucose concentrations and ACC Glc concentration (r = 0.415, n = 16, p = 0.11). e Interestingly, we observed a significant negative correlation between glucose levels in the DMS specifically, and spontaneous alternation (r = −0.658, n = 16, p = 0.006)
Fig. 3. DTI showed differences in white…
Fig. 3. DTI showed differences in white matter microstructure in brains of TALLYHO/JngJ (TH) mice compared to the control strain (SWR/J).
a The fractional anisotropy (FA) was increased in the corpus callosum (CC) (0.547 ± 0.008 vs. 0.478 ± 0.01, n = 9 per strain, p = 3.7E-05) and decreased in the dorsomedial striatum (DMS) (0.18 ± 0.01 vs. 0.20 ± 0.01, n = 9 per strain, p = 0.01) and superior cerebellar peduncle (SCP) (0.28 ± 0.02 vs. 0.36 ± 0.01, n = 9 per strain, p = 0.003) of TH mice. No differences were observed in the orbitofrontal cortex (OFC), anterior cingulate cortex (ACC), and nucleus accumbens (NAcc). b The same three brain regions showed a decrease in the mean diffusivity (MD) in TH mice: CC (7.44E-04 ± 5.56E-06 vs. 7.78E-04 ± 1.21E-05, n = 9 per strain, p = 0.03), DMS (7.17E-04 ± 1.10E-05 vs. 7.58E-04 ± 1.18E-05, n = 9 per strain, p = 0.02) and SCP (6.50E-04 ± 2.89E-05 vs. 7.44E-04 ± 1.30E-05, n = 9 per strain, p = 0.01). c, d Compulsivity-like behavior as shown by the spontaneous alternation is positively correlated to the FA in DMS and SCP (r = 0.734, n = 18, p = 0.002 and r = 0.548, n = 18, p = 0.02, respectively)
Fig. 4. TALLYHO/JngJ mice show changes in…
Fig. 4. TALLYHO/JngJ mice show changes in cerebellar and plasma Insulin-like growth factor 1 protein levels.
a The concentration of Insulin-like growth factor 1 (Igf1) is reduced in the cerebellum of TALLYHO/JngJ (TH) mice compared with their controls, SWR/J mice (90.2 ± 12.3 vs. 168.7 ± 15.5 pg/ml, n = 6 [TH] and n = 8 [SWR/J], p = 0.0002). b Interestingly, the concentration of Igf1 is increased in the blood plasma of TH mice (1217.4 ± 453.6 vs. 97.6 ± 22.2 pg/ml, n = 7 [TH] and n = 4 [SWR/J], p = 0.049)

References

    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th edn. (American Psychiatric Association, Washington, DC, 2013).
    1. Pauls DL. The genetics of obsessive-compulsive disorder: a review. Dialogues Clin. Neurosci. 2010;12:149–163.
    1. de Silva P, Marks M. The role of traumatic experiences in the genesis of obsessive–compulsive disorder. Behav. Res. Ther. 1999;37:941–951. doi: 10.1016/S0005-7967(98)00185-5.
    1. Saxena S, Rauch SL. Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr. Clin. North Am. 2000;23:563–586. doi: 10.1016/S0193-953X(05)70181-7.
    1. Menzies L, et al. Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited. Neurosci. Biobehav. Rev. 2008;32:525–549. doi: 10.1016/j.neubiorev.2007.09.005.
    1. Fitzgerald KD, et al. Developmental alterations of frontal-striatal-thalamic connectivity in obsessive-compulsive disorder. J. Am. Acad. Child Adolesc. Psychiatry. 2011;50:938–948.e933. doi: 10.1016/j.jaac.2011.06.011.
    1. Abramovitch A, Mittelman A, Henin A, Geller D. Neuroimaging and neuropsychological findings in pediatric obsessive-compulsive disorder: a review and developmental considerations. Neuropsychiatry. 2012;2:313–329. doi: 10.2217/npy.12.40.
    1. Baxter LR, Jr., et al. Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder. Am. J. Psychiatry. 1988;145:1560–1563. doi: 10.1176/ajp.145.12.1560.
    1. Whiteside SP, Port JD, Abramowitz JS. A meta-analysis of functional neuroimaging in obsessive-compulsive disorder. Psychiatry Res. 2004;132:69–79. doi: 10.1016/j.pscychresns.2004.07.001.
    1. Breiter HC, Rauch SL. Functional MRI and the study of OCD: from symptom provocation to cognitive-behavioral probes of cortico-striatal systems and the amygdala. NeuroImage. 1996;4(3 Pt 3):S127–S138. doi: 10.1006/nimg.1996.0063.
    1. Koch K, et al. Aberrant anterior cingulate activation in obsessive-compulsive disorder is related to task complexity. Neuropsychologia. 2012;50:958–964. doi: 10.1016/j.neuropsychologia.2012.02.002.
    1. Perani D, et al. [18F]FDG PET study in obsessive-compulsive disorder. A clinical/metabolic correlation study after treatment. Br. J. Psychiatry. 1995;166:244–250. doi: 10.1192/bjp.166.2.244.
    1. Swedo SE, et al. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Arch. Gen. Psychiatry. 1989;46:518–523. doi: 10.1001/archpsyc.1989.01810060038007.
    1. Pujol J, et al. Mapping structural brain alterations in obsessive-compulsive disorder. Arch. Gen. Psychiatry. 2004;61:720–730. doi: 10.1001/archpsyc.61.7.720.
    1. Kim J-J, et al. Grey matter abnormalities in obsessive—compulsive disorder. Stat. Parametric Mapp. Segmented Magn. Reson. Images. 2001;179:330–334.
    1. Nakao T, et al. Brain activation of patients with obsessive-compulsive disorder during neuropsychological and symptom provocation tasks before and after symptom improvement: a functional magnetic resonance imaging study. Biol. Psychiatry. 2005;57:901–910. doi: 10.1016/j.biopsych.2004.12.039.
    1. Anticevic A, et al. Global resting-state functional magnetic resonance imaging analysis identifies frontal cortex, striatal, and cerebellar dysconnectivity in obsessive-compulsive disorder. Biol. Psychiatry. 2014;75:595–605. doi: 10.1016/j.biopsych.2013.10.021.
    1. van de Vondervoort I, et al. An integrated molecular landscape implicates the regulation of dendritic spine formation through insulin-related signalling in obsessive-compulsive disorder. J. Psychiatry Neurosci. 2016;41:280–285. doi: 10.1503/jpn.140327.
    1. Stewart SE, et al. Genome-wide association study of obsessive-compulsive disorder. Mol. Psychiatry. 2013;18:788–798. doi: 10.1038/mp.2012.85.
    1. Mattheisen M, et al. Genome-wide association study in obsessive-compulsive disorder: results from the OCGAS. Mol. Psychiatry. 2015;20:337–344. doi: 10.1038/mp.2014.43.
    1. Lee C-C, Huang C-C, Hsu K-S. Insulin promotes dendritic spine and synapse formation by the PI3K/Akt/mTOR and Rac1 signaling pathways. Neuropharmacology. 2011;61:867–879. doi: 10.1016/j.neuropharm.2011.06.003.
    1. Winocour PH, Main CJ, Medlicott G, Anderson DC. A psychometric evaluation of adult patients with type 1 (insulin-dependent) diabetes mellitus: prevalence of psychological dysfunction and relationship to demographic variables, metabolic control and complications. Diabetes Res. 1990;14:171–176.
    1. Kontoangelos K, et al. The association of the metabolic profile in diabetes mellitus type 2 patients with obsessive-compulsive symptomatology and depressive symptomatology: new insights. Int. J. Psychiatry Clin. Pract. 2013;17:48–55. doi: 10.3109/13651501.2012.697563.
    1. Jurcovicova J. Glucose transport in brain - effect of inflammation. Endocr. Regul. 2014;48:35–48. doi: 10.4149/endo_2014_01_35.
    1. Kumagai AK. Glucose transport in brain and retina: implications in the management and complications of diabetes. Diabetes/Metab. Res. Rev. 1999;15:261–273. doi: 10.1002/(SICI)1520-7560(199907/08)15:4<261::AID-DMRR43>;2-Z.
    1. Valenciano AI, Corrochano S, de Pablo F, de la Villa P, de la Rosa EJ. Proinsulin/insulin is synthesized locally and prevents caspase- and cathepsin-mediated cell death in the embryonic mouse retina. J. Neurochem. 2006;99:524–536. doi: 10.1111/j.1471-4159.2006.04043.x.
    1. Beattie EC, et al. Regulation of AMPA receptor endocytosis by a signaling mechanism shared with LTD. Nat. Neurosci. 2000;3:1291–1300. doi: 10.1038/81823.
    1. Chiu SL, Chen CM, Cline HT. Insulin receptor signaling regulates synapse number, dendritic plasticity, and circuit function in vivo. Neuron. 2008;58:708–719. doi: 10.1016/j.neuron.2008.04.014.
    1. Wan Q, et al. Recruitment of functional GABA(A) receptors to postsynaptic domains by insulin. Nature. 1997;388:686–690. doi: 10.1038/41792.
    1. Dou JT, Chen M, Dufour F, Alkon DL, Zhao WQ. Insulin receptor signaling in long-term memory consolidation following spatial learning. Learn. Memory. 2005;12:646–655. doi: 10.1101/lm.88005.
    1. Zhao W, et al. Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats. J. Biol. Chem. 1999;274:34893–34902. doi: 10.1074/jbc.274.49.34893.
    1. Chiu SL, Cline HT. Insulin receptor signaling in the development of neuronal structure and function. Neural Dev. 2010;5:7. doi: 10.1186/1749-8104-5-7.
    1. Niswender KD, et al. Insulin activation of phosphatidylinositol 3-kinase in the hypothalamic arcuate nucleus a key mediator of insulin-induced anorexia. Diabetes. 2003;52:227–231. doi: 10.2337/diabetes.52.2.227.
    1. Margolis RU, Altszuler N. Insulin in the cerebrospinal fluid. Nature. 1967;215:1375–1376. doi: 10.1038/2151375a0.
    1. Clarke DW, Mudd L, Boyd FT, Jr., Fields M, Raizada MK. Insulin is released from rat brain neuronal cells in culture. J. Neurochemistry. 1986;47:831–836. doi: 10.1111/j.1471-4159.1986.tb00686.x.
    1. Ryu SY, Coutu JP, Rosas HD, Salat DH. Effects of insulin resistance on white matter microstructure in middle-aged and older adults. Neurology. 2014;82:1862–1870. doi: 10.1212/WNL.0000000000000452.
    1. Weinstein G, et al. Glucose indices are associated with cognitive and structural brain measures in young adults. Neurology. 2015;84:2329–2337. doi: 10.1212/WNL.0000000000001655.
    1. Kodl CT, et al. Diffusion tensor imaging identifies deficits in white matter microstructure in subjects with type 1 diabetes that correlate with reduced neurocognitive function. Diabetes. 2008;57:3083–3089. doi: 10.2337/db08-0724.
    1. Xiong Y, et al. A diffusion tensor imaging study on white matter abnormalities in patients with type 2 diabetes using tract-based spatial statistics. AJNR Am. J. Neuroradiol. 2016;37:1462–1469. doi: 10.3174/ajnr.A4740.
    1. Kim JH, et al. Phenotypic characterization of polygenic type 2 diabetes in TALLYHO/JngJ mice. J. Endocrinol. 2006;191:437–446. doi: 10.1677/joe.1.06647.
    1. Kim JH, et al. Genetic analysis of a new mouse model for non-insulin-dependent diabetes. Genomics. 2001;74:273–286. doi: 10.1006/geno.2001.6569.
    1. Mathews, C. & Leiter, E. Rodent models for the study of diabetes, 14th edn. In Joslin’s Diabetes Mellitus (eds. Kahn, C., Weir, G., King, G., Jacobson, A., Moses, A., Smith, R.) 292–328 (Lippincott Williams & Wilkins, Philadelphia, 2005).
    1. Yadin E, Friedman E, Bridger WH. Spontaneous alternation behavior: an animal model for obsessive-compulsive disorder? Pharmacol., Biochem., Behav. 1991;40:311–315. doi: 10.1016/0091-3057(91)90559-K.
    1. Walf AA, Frye CA. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat. Protoc. 2007;2:322–328. doi: 10.1038/nprot.2007.44.
    1. Zerbi V, et al. Gray and white matter degeneration revealed by diffusion in an Alzheimer mouse model. Neurobiol. Aging. 2013;34:1440–1450. doi: 10.1016/j.neurobiolaging.2012.11.017.
    1. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn. Reson. Med. 1993;30:672–679. doi: 10.1002/mrm.1910300604.
    1. Leemans, A. et al. Explore DTI: a graphical toolbox for processing, analyzing and visualizing diffusion MR data. Proc. Intl. Soc. Mag. Reson. Med.17, 3537 (2009).
    1. Lau C, et al. Exploration and visualization of gene expression with neuroanatomy in the adult mouse brain. BMC Bioinforma. 2008;9:1. doi: 10.1186/1471-2105-9-S6-S1.
    1. Schneider CA, Rasband WS, Eliceiri KW. NIH image to ImageJ: 25 years of image analysis. Nat. Methods. 2012;9:671–675. doi: 10.1038/nmeth.2089.
    1. Grubbs FE. Procedures for detecting outlying observations in samples. Technometrics. 1969;11:1–21. doi: 10.1080/00401706.1969.10490657.
    1. Benjamin, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B57, 289–300 (1995).
    1. Mao X, Dillon KD, McEntee MF, Saxton AM, Kim JH. Islet insulin secretion, β-cell mass, and energy balance in a polygenic mouse model of type 2 diabetes with obesity. J. Inborn Errors Metab. Screen. 2014;2:2326409814528153. doi: 10.1177/2326409814528153.
    1. Rosso G, et al. Serum levels of insulin-like growth factor-1 and obsessive-compulsive disorder: a case-control study. Neuropsychobiology. 2016;74:15–21. doi: 10.1159/000446918.
    1. Yamagata K, et al. Voltage-gated K+ channel KCNQ1 regulates insulin secretion in MIN6 beta-cell line. Biochemical Biophysical Res. Commun. 2011;407:620–625. doi: 10.1016/j.bbrc.2011.03.083.
    1. Taylor S. Etiology of obsessions and compulsions: a meta-analysis and narrative review of twin studies. Clin. Psychol. Rev. 2011;31:1361–1372. doi: 10.1016/j.cpr.2011.09.008.
    1. Maina G, et al. Serum levels of brain-derived neurotrophic factor in drug-naive obsessive-compulsive patients: a case-control study. J. Affect Disord. 2010;122:174–178. doi: 10.1016/j.jad.2009.07.009.
    1. Fontenelle LF, et al. Neurotrophic factors in obsessive-compulsive disorder. Psychiatry Res. 2012;199:195–200. doi: 10.1016/j.psychres.2012.03.034.
    1. Duan W, Guo Z, Jiang H, Ware M, Mattson MP. Reversal of behavioral and metabolic abnormalities, and insulin resistance syndrome, by dietary restriction in mice deficient in brain-derived neurotrophic factor. Endocrinology. 2003;144:2446–2453. doi: 10.1210/en.2002-0113.
    1. Collins MM, Corcoran P, Perry IJ. Anxiety and depression symptoms in patients with diabetes. Diabet. Med. 2009;26:153–161. doi: 10.1111/j.1464-5491.2008.02648.x.
    1. Brennan BP, et al. Lower posterior cingulate cortex glutathione levels in obsessive-compulsive disorder. Biol. Psychiatry.: Cogn. Neurosci. Neuroimaging. 2016;1:116–124.
    1. Orhan N, Kucukali CI, Cakir U, Seker N, Aydin M. Genetic variants in nuclear-encoded mitochondrial proteins are associated with oxidative stress in obsessive compulsive disorders. J. Psychiatr. Res. 2012;46:212–218. doi: 10.1016/j.jpsychires.2011.09.012.
    1. Mintzopoulos D, et al. Striatal magnetic resonance spectroscopy abnormalities in young adult SAPAP3 knockout mice. Biol. Psychiatry.: Cogn. Neurosci. Neuroimaging. 2016;1:39–48.
    1. Guldenpfennig M, Wolmarans de W, du Preez JL, Stein DJ, Harvey BH. Cortico-striatal oxidative status, dopamine turnover and relation with stereotypy in the deer mouse. Physiol. Behav. 2011;103:404–411. doi: 10.1016/j.physbeh.2011.03.008.
    1. Kim SK, Woodcroft KJ, Khodadadeh SS, Novak RF. Insulin signaling regulates gamma-glutamylcysteine ligase catalytic subunit expression in primary cultured rat hepatocytes. J. Pharm. Exp. Ther. 2004;311:99–108. doi: 10.1124/jpet.104.070375.
    1. Gonzalez-Santiago L, et al. Aplidin induces JNK-dependent apoptosis in human breast cancer cells via alteration of glutathione homeostasis, Rac1 GTPase activation, and MKP-1 phosphatase downregulation. Cell Death Differ. 2006;13:1968–1981. doi: 10.1038/sj.cdd.4401898.
    1. Uranga RM, Katz S, Salvador GA. Enhanced phosphatidylinositol 3-kinase (PI3K)/Akt signaling has pleiotropic targets in hippocampal neurons exposed to iron-induced oxidative stress. J. Biol. Chem. 2013;288:19773–19784. doi: 10.1074/jbc.M113.457622.
    1. Koch K, Reess TJ, Rus OG, Zimmer C, Zaudig M. Diffusion tensor imaging (DTI) studies in patients with obsessive-compulsive disorder (OCD): a review. J. Psychiatr. Res. 2014;54:26–35. doi: 10.1016/j.jpsychires.2014.03.006.
    1. Yoo SY, et al. White matter abnormalities in drug-naive patients with obsessive-compulsive disorder: a diffusion tensor study before and after citalopram treatment. Acta Psychiatr. Scandinavica. 2007;116:211–219. doi: 10.1111/j.1600-0447.2007.01046.x.
    1. Fan Q, et al. Abnormalities of white matter microstructure in unmedicated obsessive-compulsive disorder and changes after medication. PLoS ONE. 2012;7:e35889. doi: 10.1371/journal.pone.0035889.
    1. Rosso IM, et al. Brain white matter integrity and association with age at onset in pediatric obsessive-compulsive disorder. Biol. Mood Anxiety Disord. 2014;4:13. doi: 10.1186/s13587-014-0013-6.
    1. Jayarajan RN, et al. White matter abnormalities in children and adolescents with obsessive-compulsive disorder: a diffusion tensor imaging study. Depress Anxiety. 2012;29:780–788. doi: 10.1002/da.21890.
    1. Hartmann T, Vandborg S, Rosenberg R, Sorensen L, Videbech P. Increased fractional anisotropy in cerebellum in obsessive-compulsive disorder. Acta Neuropsychiatrica. 2016;28:141–148. doi: 10.1017/neu.2015.57.
    1. Kleinridders, A. Deciphering brain insulin receptor and insulin-like growth factor 1 receptor signalling. J. Neuroendocrinol. 28, 1–13 (2016).
    1. Croci L, et al. Local insulin-like growth factor I expression is essential for Purkinje neuron survival at birth. Cell Death Differ. 2011;18:48–59. doi: 10.1038/cdd.2010.78.
    1. De Keyser J, Wilczak N, De Backer JP, Herroelen L, Vauquelin G. Insulin-like growth factor-I receptors in human brain and pituitary gland: an autoradiographic study. Synapse. 1994;17:196–202. doi: 10.1002/syn.890170309.
    1. Garcia-Segura LM, Rodriguez JR, Torres-Aleman I. Localization of the insulin-like growth factor I receptor in the cerebellum and hypothalamus of adult rats: an electron microscopic study. J. Neurocytol. 1997;26:479–490. doi: 10.1023/A:1018581407804.
    1. Cheng CM, et al. Insulin-like growth factor 1 is essential for normal dendritic growth. J. Neurosci. Res. 2003;73:1–9. doi: 10.1002/jnr.10634.
    1. Sherrard RM, Bower AJ. IGF-1 induces neonatal climbing-fibre plasticity in the mature rat cerebellum. Neuroreport. 2003;14:1713–1716. doi: 10.1097/00001756-200309150-00011.
    1. Nagarajan, N., Jones, B. W., West, P. J., Marc, R. E. & Capecchi, M. R. Corticostriatal circuit defects in Hoxb8 mutant mice. Mol. Psychiatry23, 1868–1877 (2018).
    1. Welch JM, et al. Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature. 2007;448:894–900. doi: 10.1038/nature06104.
    1. Wan Y, et al. Circuit-selective striatal synaptic dysfunction in the Sapap3 knockout mouse model of obsessive-compulsive disorder. Biol. Psychiatry. 2014;75:623–630. doi: 10.1016/j.biopsych.2013.01.008.
    1. Wan Y, Feng G, Calakos N. Sapap3 deletion causes mGluR5-dependent silencing of AMPAR synapses. J. Neurosci. 2011;31:16685–16691. doi: 10.1523/JNEUROSCI.2533-11.2011.

Source: PubMed

3
Tilaa